485 related articles for article (PubMed ID: 872954)
1. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
Leis D; Botterman P; Ermler R; Maurer U
Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
[TBL] [Abstract][Full Text] [Related]
3. The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test.
Aznar R; Lara R; Zarco D; González L
Contraception; 1976 Mar; 13(3):299-311. PubMed ID: 55331
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
7. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of contraceptive steroids. III. Intravenous glucose tolerance--short term observations.
Mangat HK; Chaudhury RR; Devi PK
J Asian Fed Obstet Gynaecol; 1972 Dec; 3(2):107-11. PubMed ID: 12310409
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives: effects on plasma insulin response to glucose and on the response to insulin and 2-deoxyglucose uptake by peripheral tissue.
Lei KY; Yang MG; Oberleas D; Prasad AS
Proc Soc Exp Biol Med; 1975 Jun; 149(2):417-21. PubMed ID: 1153418
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate metabolism of Indian women taking steroid contraceptives.
Barsivala VM; Virkar K; Kulkarni RD
Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
[TBL] [Abstract][Full Text] [Related]
12. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
13. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
Hausmann L; Goebel KM; Zehner J
Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
[TBL] [Abstract][Full Text] [Related]
14. Effects of low-dose gestagen (lynestrenol 0.5 mg) and combination-type oral contraception (lynestrenol 1 mg and ethinyloestradiol 0.05 mg) on blood glucose and serum insulin levels after a glucose load.
Leis D; Bottermann P; Ermler R; Schlauch W
Arch Gynecol; 1980; 230(2):143-7. PubMed ID: 7006521
[TBL] [Abstract][Full Text] [Related]
15. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
16. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
Spellacy WN; Tsibris JC; Hunter-Bonner DL; Smalling S; Chez RA; Angel JL; O'Brien WF
Contraception; 1992 Jun; 45(6):533-9. PubMed ID: 1617962
[TBL] [Abstract][Full Text] [Related]
17. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components.
Rangnekar KN; Rao SS; Joshi UM
Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol.
de la Pena A; Chenault CB; Goldzieher JW
Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
Brenner PF; Goebelsmann U; Stanczyk FZ; Mishell DR
Contraception; 1980 Jul; 22(1):85-95. PubMed ID: 7418409
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a new triphasic oral contraceptive in private practice.
Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]